The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 29, 2023
Filed:
Aug. 11, 2021
Applicant:
The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);
Inventors:
Helen M. Blau, Stanford, CA (US);
Adelaida R. Palla, Stanford, CA (US);
Andrew Tri Van Ho, Paris, FR;
Assignee:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, Stanford, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/5575 (2006.01); A61K 45/06 (2006.01); A61K 38/17 (2006.01); A61K 35/64 (2015.01); A61K 35/583 (2015.01); A61P 21/06 (2006.01); A61K 31/167 (2006.01); A61K 31/245 (2006.01); A61K 31/46 (2006.01); A61K 31/47 (2006.01); A61K 33/00 (2006.01); A61K 33/06 (2006.01); A61K 33/24 (2019.01); A61K 33/32 (2006.01); A61K 38/46 (2006.01); A61P 21/00 (2006.01); A61K 9/00 (2006.01); A61K 31/445 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5575 (2013.01); A61K 9/0019 (2013.01); A61K 31/167 (2013.01); A61K 31/245 (2013.01); A61K 31/445 (2013.01); A61K 31/46 (2013.01); A61K 31/47 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 33/32 (2013.01); A61K 35/583 (2013.01); A61K 35/64 (2013.01); A61K 38/1703 (2013.01); A61K 38/465 (2013.01); A61K 45/06 (2013.01); A61P 21/00 (2018.01); A61P 21/06 (2018.01);
Abstract
Provided herein are compositions for preventing or treating muscle conditions such as muscle damage, injury, or atrophy. In some embodiments, the compositions comprise a prostaglandin E2 (PGE2) compound and a myotoxin. In some embodiments, the muscle damage, injury, or atrophy is the result of a nerve injury, a surgical procedure, or a traumatic injury. Methods of promoting muscle regeneration and methods of increasing muscle mass are also provided herein.